A multicenter, non-randomized, phase II study of docetaxel and carboplatin administered every 3 weeks as second line chemotherapy in patients with first relapse of platinum sensitive epithelial ovarian, peritoneal or fallopian tube cancer

Yun Wang; Jørn Herrstedt; Hanne Havsteen; Rene DePoint Christensen; Mansoor Raza Mirza; Bente Lund; Johanna Maenpaa; Gunnar Kristensen

doi:10.1186/1471-2407-14-937

A multicenter, non-randomized, phase II study of docetaxel and carboplatin administered every 3 weeks as second line chemotherapy in patients with first relapse of platinum sensitive epithelial ovarian, peritoneal or fallopian tube cancer

Yun Wang, Jørn Herrstedt, Hanne Havsteen, Rene DePoint Christensen, Mansoor Raza Mirza, Bente Lund, Johanna Maenpaa, Gunnar Kristensen

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

9 Citationer (Scopus)

Originalsprog	Engelsk
Artikelnummer	937
Tidsskrift	B M C Cancer
Vol/bind	2014
Udgave nummer	14
ISSN	1471-2407
DOI	https://doi.org/10.1186/1471-2407-14-937
Status	Udgivet - 2014

Adgang til dokumentet

10.1186/1471-2407-14-937

http://www.biomedcentral.com/1471-2407/14/937/abstract

AUB Link

Søg efter materialet i Aalborg Universitetsbiblioteks søgemaskine

Citationsformater

Wang, Y., Herrstedt, J., Havsteen, H., Christensen, R. D., Mirza, M. R., Lund, B., Maenpaa, J., & Kristensen, G. (2014). A multicenter, non-randomized, phase II study of docetaxel and carboplatin administered every 3 weeks as second line chemotherapy in patients with first relapse of platinum sensitive epithelial ovarian, peritoneal or fallopian tube cancer. B M C Cancer, 2014(14), Artikel 937. https://doi.org/10.1186/1471-2407-14-937

@article{018c2b61916c43d1885aea1ea403021e,

title = "A multicenter, non-randomized, phase II study of docetaxel and carboplatin administered every 3 weeks as second line chemotherapy in patients with first relapse of platinum sensitive epithelial ovarian, peritoneal or fallopian tube cancer",

author = "Yun Wang and J{\o}rn Herrstedt and Hanne Havsteen and Christensen, {Rene DePoint} and Mirza, {Mansoor Raza} and Bente Lund and Johanna Maenpaa and Gunnar Kristensen",

year = "2014",

doi = "10.1186/1471-2407-14-937",

language = "English",

volume = "2014",

journal = "B M C Cancer",

issn = "1471-2407",

publisher = "BioMed Central",

number = "14",

}

Wang, Y, Herrstedt, J, Havsteen, H, Christensen, RD, Mirza, MR, Lund, B, Maenpaa, J & Kristensen, G 2014, 'A multicenter, non-randomized, phase II study of docetaxel and carboplatin administered every 3 weeks as second line chemotherapy in patients with first relapse of platinum sensitive epithelial ovarian, peritoneal or fallopian tube cancer', B M C Cancer, bind 2014, nr. 14, 937. https://doi.org/10.1186/1471-2407-14-937

A multicenter, non-randomized, phase II study of docetaxel and carboplatin administered every 3 weeks as second line chemotherapy in patients with first relapse of platinum sensitive epithelial ovarian, peritoneal or fallopian tube cancer. / Wang, Yun; Herrstedt, Jørn; Havsteen, Hanne et al.
I: B M C Cancer, Bind 2014, Nr. 14, 937, 2014.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

TY - JOUR

T1 - A multicenter, non-randomized, phase II study of docetaxel and carboplatin administered every 3 weeks as second line chemotherapy in patients with first relapse of platinum sensitive epithelial ovarian, peritoneal or fallopian tube cancer

AU - Wang, Yun

AU - Herrstedt, Jørn

AU - Havsteen, Hanne

AU - Christensen, Rene DePoint

AU - Mirza, Mansoor Raza

AU - Lund, Bente

AU - Maenpaa, Johanna

AU - Kristensen, Gunnar

PY - 2014

Y1 - 2014

U2 - 10.1186/1471-2407-14-937

DO - 10.1186/1471-2407-14-937

M3 - Journal article

SN - 1471-2407

VL - 2014

JO - B M C Cancer

JF - B M C Cancer

IS - 14

M1 - 937

ER -

Wang Y, Herrstedt J, Havsteen H, Christensen RD, Mirza MR, Lund B et al. A multicenter, non-randomized, phase II study of docetaxel and carboplatin administered every 3 weeks as second line chemotherapy in patients with first relapse of platinum sensitive epithelial ovarian, peritoneal or fallopian tube cancer. B M C Cancer. 2014;2014(14):937. doi: 10.1186/1471-2407-14-937